Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve

Tracy Y. Wang; Lars G. Svensson; Jun Wen; Andrew Vekstein; Marc Gerdisch; Vijay U. Rao; Michael Moront; Doug Johnston; Renato D. Lopes; Alma Chavez; Marc Ruel; Eugene H. Blackstone; Richard C. Becker; Vinod Thourani; John Puskas; Hussein R. Al-Khalidi; David G. Cable; John A. Elefteriades; Alberto Pochettino; J. Alan Wolfe; Allen Graeve; Ibrahim Sultan; Ashraf A. Sabe; Hector I. Michelena; John H. Alexander

Journal ArticleOPEN ACCESS

Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve

Wang T
Svensson L
Wen J
et al.

NEJM Evidence (2023) 2(7)

DOI: 10.1056/evidoa2300067

N/ACitations

96Readers

Abstract

Vitamin K antagonists are the only oral anticoagulants approved to prevent valve thrombosis and valve-related thromboembolism in patients with mechanical heart valves. Whether patients with an On-X...

Cite

CITATION STYLE

APA

Wang, T. Y., Svensson, L. G., Wen, J., Vekstein, A., Gerdisch, M., Rao, V. U., … Alexander, J. H. (2023). Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve. NEJM Evidence, 2(7). https://doi.org/10.1056/evidoa2300067

Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve

Abstract

Cite

Register to see more suggestions